CDCA3 (cell division cycle associated 3)

2013-01-01  

Identity

HGNC
CDCA3
LOCATION
12p13.31
LOCUSID
83461
ALIAS
GRCC8,TOME-1

Other Information

Locus ID:

NCBI: 83461
MIM: 607749
HGNC: 14624
Ensembl: ENSG00000111665

Variants:

dbSNP: 83461
ClinVar: 83461
TCGA: ENSG00000111665
COSMIC: CDCA3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000111665ENST00000229265J3KMY0
ENSG00000111665ENST00000422785F8WDL1
ENSG00000111665ENST00000535406Q99618
ENSG00000111665ENST00000538862Q99618
ENSG00000111665ENST00000540683F5GX58

Expression (GTEx)

0
5
10
15
20
25
30
Adipose - Subcutaneous
Adipose - Visceral
Adrenal Gland
Artery - Aorta
Artery - Tibial
Bladder
Brain - Amygdala
Brain - Anterior cingulate cortex
Brain - Caudate
Brain - Cerebellar Hemisphere
Brain - Cerebellum
Brain - Cortex
Brain - Frontal Cortex
Brain - Hippocampus
Brain - Hypothalamus
Brain - Nucleus accumbens
Brain - Putamen
Brain - Spinal cord
Brain - Substantia nigra
Breast - Mammary Tissue
Cells - Cultured fibroblasts
Cells - EBV - transformed lymphocytes
Cervix - Ectocervix
Cervix - Endocervix
Colon - Sigmoid
Colon - Transverse
Esophagus - Gastroesophageal Junction
Esophagus - Mucosa
Esophagus - Muscularis
Fallopian Tube
Heart - Atrial Appendage
Heart - Left Ventricle
Kidney - Cortex
Kidney - Medulla
Liver
Lung
Minor Salivary Gland
Muscle - Skeletal
Nerve - Tibial
Ovary
Pancreas
Pituitary
Prostate
Skin - Not Sun Exposed
Skin - Sun Exposed
Small Intestine - Terminal Ileum
Spleen
Stomach
Testis
Thyroid
Uterus
Vagina
Whole Blood

References

Pubmed IDYearTitleCitations
376258242023Identification of circ_0038632 as a Promoter of Breast Cancer through miR-520a-3p-Dependent Modulation of CDCA3.0
376258242023Identification of circ_0038632 as a Promoter of Breast Cancer through miR-520a-3p-Dependent Modulation of CDCA3.0
349706972022Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.8
352307452022LncCDCA3L inhibits cell proliferation via a novel RNA structure-based crosstalk with CDCA3 in hepatocellular carcinoma.2
360712752022MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.12
360813202022CDCA3 exhibits a role in promoting the progression of ovarian cancer.1
360874622022MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells.3
349706972022Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.8
352307452022LncCDCA3L inhibits cell proliferation via a novel RNA structure-based crosstalk with CDCA3 in hepatocellular carcinoma.2
360712752022MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.12
360813202022CDCA3 exhibits a role in promoting the progression of ovarian cancer.1
360874622022MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells.3
336043802021CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.13
338242812021Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression.13
340502472021Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy.11

Citation

Dessen P

CDCA3 (cell division cycle associated 3)

Atlas Genet Cytogenet Oncol Haematol. 2013-01-01

Online version: http://atlasgeneticsoncology.org/gene/53126